Skye Opsteen,Nathaniel Erdmann
Skye Opsteen
The COVID-19 pandemic has contributed to more than 7 million deaths globally and has triggered a variety of postacute sequelae, now commonly referred to as long COVID, in millions more. Early efforts during the pandemic resulted in several ...
Attention-deficit/hyperactivity disorder, autism spectrum disorder, and HIV: implications for risk, outcomes, and care for neurodivergent people [0.03%]
注意缺陷多动障碍、自闭症谱系障碍与艾滋病：对神经多样人群风险、结局及护理的启示
Heather M Relyea Ashley,Sara K Stuart,Ellen F Eaton
Heather M Relyea Ashley
Neurodivergence, including autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), is increasingly recognized as an important factor influencing health across the lifespan. Although ASD and ADHD are diagnosed cat...
Interventions and opportunities to enhance aging among people with HIV: a focus on frailty, sarcopenia, and intrinsic capacity [0.03%]
促进艾滋病病毒感染者健康老龄化：关注脆弱性、肌少症和内在能力
Evelyn Iriarte,Kristine M Erlandson
Evelyn Iriarte
Antiretroviral therapy has transformed HIV into a chronic condition, resulting in a growing population of older people with HIV (PWH). This shift has been accompanied by an increased burden of age-related conditions, including frailty and s...
Selected highlights from the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs [0.03%]
第26届临床抗病毒药物研讨会议亮点——艾滋病、肝炎等其他抗病毒药物
Kimberly K Scarsi,Catia Marzolini,Fiona Marra et al.
Kimberly K Scarsi et al.
Clinical pharmacology plays a crucial role in the successful treatment and prevention of HIV and other viral infections. Information from the field of clinical pharmacology leads to the development of novel antiviral treatments, supports th...
Weight gain and obesity management in people with HIV: pathophysiology, antiretroviral therapy effects, and clinical strategies [0.03%]
HIV感染者的体重增加和肥胖管理：病理生理学、抗逆转录病毒疗法的影响及临床策略
Danna Kashlan,Zoobia Chaudhry
Danna Kashlan
Obesity is a chronic, relapsing disease that is defended by complex biologic regulatory mechanisms, and is defined by excessive or abnormal adipose tissue that impairs health. Among people with HIV (PWH), the epidemiology of body weight has...
Current evidence on islatravir drug resistance and implications for future HIV treatment [0.03%]
Islatravir药物耐药性现有证据及其对未来HIV治疗的启示
Annemarie M Wensing,Vincent Calvez,Francesca Ceccherini-Silberstein et al.
Annemarie M Wensing et al.
Islatravir (ISL; MK-8591; 4'-ethynyl-2-fluoro-2'-deoxyadenosine; EFdA) is the first antiviral drug that acts as a nucleoside reverse transcriptase translocation inhibitor (NRTTI). Unlike classic nucleoside and nucleotide analogue reverse tr...
CROI 2026: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases [0.03%]
2026年CROI：艾滋病和其他性传播疾病的全球流行病学和预防
Susan P Buchbinder,Albert Y Liu
Susan P Buchbinder
At the 2026 Conference on Retroviruses and Opportunistic Infections (CROI), investigators presented updates on the global HIV epidemic. HIV incidence remains high among key populations, including female sex workers, men who have sex with me...
Annukka A R Antar
Annukka A R Antar
The 2026 Conference on Retroviruses and Opportunistic Infections (CROI) furthered our understanding of acute COVID-19, long COVID, postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), viral immunity, and SARS-...
Sudipa Sarkar,Todd T Brown
Sudipa Sarkar
Aging-related comorbid conditions have major effects on the health, quality of life, and survival of people with HIV (PWH). The 2026 Conference on Retroviruses and Opportunistic Infections (CROI) featured a number of studies about various c...
CROI 2026: Advances in Epidemiology and Treatment of Viral Hepatitis [0.03%]
2026年CROI会议：病毒性肝炎流行病学和治疗的进展
Shauna H Gunaratne
Shauna H Gunaratne
The 2026 Conference on Retroviruses and Opportunistic Infections (CROI) highlighted hepatitis B outcomes in people with HIV on non-hepatitis B-active regimens. Advances in hepatitis B treatment were covered, with some abstracts highlighting...